Bioactive Compounds
-
BA1065 PristinamycinSummary: Pristinamycin is an orally active streptomycin-like antibiotic produced in , Pristinamycin consists of two chemically unrelated components: pristinamycinI (PI) and pristinamycinII (PII). -
BA3019 OTS193320Summary: OTS193320 is an imidazo[1,2-a]pyridine compound, an inhibitor of methyltransferase activity. -
BA4556 DACASummary: DACA inhibits two essential nucleases, DNA topoisomerase I (topoI) and DNA topoisomerase II (topoII), in vitro. -
BA9351 N-Benzyl-L-isoleucineSummary: An isoleucine derivative. -
C8326 Boc-Glu-Lys-Lys-AMCSummary: A sensitive fluorescent substrate for urokinase-activated fibrinolysis (plasmin). -
C8654 LinrodostatSummary: A selective, irreversible indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor -
BA1063 CefotetanSummary: Cefotetan is a semi-synthetic cephalomycin antibiotic. -
BA4555 RazoxaneSummary: Razoxane (ICRF159) is an anti-angiogenic topoisomerase II inhibitor. -
BA9336 N-Methyl-L-threonineSummary: A threonine derivative. -
C8325 DFAMESummary: DFAME is a red fluorescent group (Ex=508nm

